Prevalence of Elevated Testosterone in PCOS
Approximately 75% of patients with PCOS have elevated testosterone levels, with free testosterone being the most sensitive marker, elevated in approximately 58-70% of cases, while total testosterone is elevated in only about 33% of patients. 1, 2
Evidence from International Guidelines
The 2023 International PCOS Guidelines, based on systematic review and meta-analysis, clearly establish that hyperandrogenism is present in 75% of PCOS cases and serves as both a diagnostic criterion and pathogenic contributor. 1
Specific Testosterone Measurements
Free Testosterone
- Free testosterone is the single most predictive biochemical marker, with supranormal levels present in 57.6% to 70% of PCOS patients diagnosed by NIH 1990 criteria. 2, 3
- This represents the highest sensitivity among androgen measurements for detecting biochemical hyperandrogenism. 2
Total Testosterone
- Total testosterone is elevated in only 33% of PCOS patients, making it less sensitive than free testosterone despite being commonly measured. 2
- However, total testosterone remains a recommended first-line test per 2023 guidelines due to its specificity (86%) when using LC-MS/MS methodology. 1
Combined Androgen Elevations
- When assessing any elevated androgen (total testosterone, free testosterone, or DHEAS), approximately 75.3% of PCOS patients demonstrate hyperandrogenemia. 2
- Simultaneous elevation of both total and free testosterone occurs in 20.4% of patients. 2
- All three markers (total testosterone, free testosterone, and DHEAS) are simultaneously elevated in only 8.7% of cases. 2
Clinical Implications
Measurement Method Matters
- LC-MS/MS demonstrates superior sensitivity and specificity compared to direct immunoassay methods for measuring testosterone. 1
- Free testosterone by direct immunoassay is highly inaccurate due to low serum concentrations and should be avoided. 1
- Calculated free testosterone or free androgen index (FAI) should be used instead of direct free testosterone immunoassays. 1
Body Weight Influences Phenotype
- Lean PCOS patients show higher total testosterone, androstenedione, and LH levels, suggesting neuroendocrine-mediated ovarian androgen production. 4
- Obese PCOS patients demonstrate lower SHBG and higher free testosterone, with hyperandrogenemia primarily driven by insulin resistance rather than absolute testosterone elevation. 4
Important Caveats
- Not all PCOS patients have elevated testosterone: approximately 25% of PCOS cases do not demonstrate hyperandrogenemia, as PCOS can be diagnosed based on ovulatory dysfunction and polycystic ovary morphology alone. 1
- The specific percentage varies depending on which diagnostic criteria are used (NIH 1990, Rotterdam 2003, or AE-PCOS 2006). 1
- Reference ranges must be established for each laboratory using regularly ovulating women in the early follicular phase, as normative values vary by assay method, ethnicity, and age. 1, 3